ATM and B-cell chronic lymphocytic leukemia: Thus, our results suggest that the integration of molecular markers, such as ATM mutations, and the FISH analysis, in patients showing loss of 11q could provide a better prognostic stratification than has been recently demonstrated in other CLL patients [20].